Related Experiment Videos
[Coagulation dysfunctions in patients with systemic inflammatory response syndrome]
1The Emergency Department of Chaoyang Hospital, Chaoyang Capital University of Medical Sciences, Beijing 100020, China. liuyugeng770@sohu.com
Zhonghua Nei Ke Za Zhi
|April 3, 2004
Summary
Systemic inflammatory response syndrome (SIRS) involves coagulation dysfunctions, particularly in the fibrinolytic system. Elevated D-dimer and plasminogen-activator inhibitor-1 (PAI-1) levels are linked to poor SIRS prognosis.
Area of Science:
- Coagulation and Thrombosis
- Systemic Inflammation
- Critical Care Medicine
Context:
- Systemic inflammatory response syndrome (SIRS) is a complex clinical condition.
- Coagulation dysfunctions are increasingly recognized in SIRS pathogenesis.
- Understanding these links is crucial for patient outcomes.
Purpose:
- To investigate the impact of coagulation abnormalities on SIRS development.
- To identify specific coagulation markers associated with SIRS and prognosis.
Summary:
- Patients with SIRS exhibited significant differences in coagulation markers compared to non-SIRS individuals and healthy controls.
- Elevated thrombin time (TT), activated partial thromboplastin time (APTT), D-dimer, thrombomodulin (TM), and plasminogen-activator inhibitor-1 (PAI-1) were observed in SIRS patients.
- Lower levels of protein C (PC), protein S (PS), tissue plasminogen activator (TPA), platelets (PLT), and fibrinogen (FBG) were noted in the SIRS group.
Impact:
- Coagulation dysfunctions, especially within the fibrinolytic system, are integral to SIRS.
- Elevated PAI-1 and D-dimer levels serve as negative prognostic indicators in SIRS.
- This research highlights potential biomarkers for assessing SIRS severity and patient outcomes.